Trency Gu is the managing director at Sequoia Capital in their Shanghai Office, focusing on healthcare investments, with a concentration on biotech, molecular diagnostics and precision medicine.
Prior to joining Sequoia, Dr. Gu worked as an associate on OrbiMed’s Asia team, covering healthcare and life sciences investments. Prior to OrbiMed, she worked as a project manager at the Eli Lilly Global External Research and Development Center in Shanghai, responsible for scouting, collaboration and partnership activities. Dr. Gu also worked at Shanghai Genomics, an innovative drug discovery and development biotech company, as director for development planning. Dr. Gu earned a bachelor of science degree with double majors in biotechnology and English and a doctor of philosophy degree in biochemistry and molecular biology from Shanghai Jiao Tong University in Shanghai.